Multiply indicted the last few minutes. First of all, before we do anything else, im going to ask unanimous consent that nonsubcommittee members be allowed to participate in the hearing. After all subcommittee members have had an opportunity to ask questions, is there any objection . If not, so ordered. So subcommittee nonsubcommittee members will be recognized at the appropriate time for five minutes. Welcome to our hearing and thank you, witnesses, for being here. We have mr. John hill, the Deputy Assistant secretary of defense for space and Missile Defense policy. Joining him Lieutenant General thomas james, the Deputy Commander of the u. S. Space command. Lieutenant general heath kohler, of the Missile Defense agency and sean gainey, commander of u. S. Army space and missiles command. And meeting to review the fiscal year, and i have concerns, the overall level of funding is inadequate given the threat environment. The fiscal year 25 budget asks 10. 4 billion dollars for the Missil
Killed by the house commerce subcommittee on health with representatives from the pharmaceutical industry and policy stakeholders. This is three hours. [inaudible conversations] [inaudible conversations] we will come to order. The committee will come to order and the chair will recognize himself for an opening statement. Todays hearing is focus on the critical topic of finding longterm solutions to prevent future drug shortages of key drugs for patients. For months, Cancer Patients including pediatric Cancer Patients, have had to scramble to find the drugs recommended or use alternatives because of instability in the markets and supply chains. In 2022 alone there were over, there were 301 drugs enacted shortages according to the university of utah. For over a decade professions and a medical and Regulatory Community has sounded the alarm on the underlying economic causes of drug shortages. Unforeseen circumstances like a tornado hitting a pharmaceutical warehouse in North Carolina, or
Must have the ability of Economic Holdings and managers. I have to say this to the people so that you can see, now there are Different Holdings in our national fund. It is very big, for example, petrishim jam company has a very high financial balance and subsidiaries that have a fund. But how many percent . From the rights of the country. Or we can give 400 from all these funds and holdings, which means that practically 96 of the money we pay is paid by the government. What they want to do in the work that petrochemicals is an expert in, should be an expert in this discussion, and of course healthy and committed, which is definitely one of our red lines, should be done in their system and be sympathetic, we can, we can use the income of this funds now my fund is only a country a social Investment Company called 60, well, if this company is really managed properly, there are many things that each of us is missing about 10 times in the discussion of the organization, so how many percenta
Subcommittee on health with representatives from the pharmaceutical industry and policy stakeholders. This is three hours. [inaudible conversations] [inaudible conversations] we will come to order. The committee will come to order and the chair will recognize himself for an opening statement. Todays hearing is focus on the critical topic of finding longterm solutions to prevent future drug shortages of key drugs for patients. For months, Cancer Patients including pediatric Cancer Patients, have had to scramble to find the drugs recommended or use alternatives because of instability in the markets and supply chains. In 2022 alone there were over, there were 301 drugs enacted shortages according to the university of utah. For over a decade professions and a medical and Regulatory Community has sounded the alarm on the underlying economic causes of drug shortages. Unforeseen circumstances like a tornado hitting a pharmaceutical warehouse in North Carolina, or a manufacturing facility in i
Subcommittee on health with representatives from the pharmaceutical industry and policy stakeholders. This is three hours. [inaudible conversations] [inaudible conversations] we will come to order. The committee will come to order and the chair will recognize himself for an opening statement. Todays hearing is focus on the critical topic of finding longterm solutions to prevent future drug shortages of key drugs for patients. For months, Cancer Patients including pediatric Cancer Patients, have had to scramble to find the drugs recommended or use alternatives because of instability in the markets and supply chains. In 2022 alone there were over, there were 301 drugs enacted shortages according to the university of utah. For over a decade professions and a medical and Regulatory Community has sounded the alarm on the underlying economic causes of drug shortages. Unforeseen circumstances like a tornado hitting a pharmaceutical warehouse in North Carolina, or a manufacturing facility in i